These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7043166)
1. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Vague P; Moulin JP Metabolism; 1982 Feb; 31(2):139-42. PubMed ID: 7043166 [TBL] [Abstract][Full Text] [Related]
2. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function]. Li X; Zhou ZG; Qi HY; Chen XY; Huang G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594 [TBL] [Abstract][Full Text] [Related]
3. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183 [TBL] [Abstract][Full Text] [Related]
4. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients. Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183 [TBL] [Abstract][Full Text] [Related]
5. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus. Turner RC; Holman RR Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115 [TBL] [Abstract][Full Text] [Related]
6. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects. Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892 [TBL] [Abstract][Full Text] [Related]
8. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Kjems LL; Vølund A; Madsbad S Diabetologia; 2001 Oct; 44(10):1339-48. PubMed ID: 11692185 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Hendriksen C; Faber OK; Drejer J; Binder C Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408 [TBL] [Abstract][Full Text] [Related]
10. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function. Damsgaard EM; Faber O; Frøland A; Iversen S Acta Endocrinol (Copenh); 1982 Jul; 100(3):416-20. PubMed ID: 7051723 [TBL] [Abstract][Full Text] [Related]
12. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Madsbad S; Krarup T; Reguer L; Faber OK; Binder C Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Pfeifer MA; Halter JB; Graf R; Porte D Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327 [TBL] [Abstract][Full Text] [Related]
14. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. McCulloch DK; Raghu PK; Johnston C; Klaff LJ; Kahn SE; Beard JC; Ward WK; Benson EA; Koerker DJ; Bergman RN J Clin Endocrinol Metab; 1988 Oct; 67(4):785-92. PubMed ID: 3047163 [TBL] [Abstract][Full Text] [Related]
15. Parallel dysfunctions of pancreatic A, B and PP cells in insulin dependent diabetes. Nonaka K; Toyoshima H; Hanafusa T; Tarui S Endocrinol Jpn; 1980 Dec; 27 Suppl 1():127-33. PubMed ID: 7014203 [TBL] [Abstract][Full Text] [Related]
16. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide]. Vague P; Ramahandridona G; Vialettes B Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823 [TBL] [Abstract][Full Text] [Related]
17. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion. Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232 [TBL] [Abstract][Full Text] [Related]
18. Impact of family history of diabetes on the assessment of beta-cell function. Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741 [TBL] [Abstract][Full Text] [Related]
19. C-peptide response to glucagon in young diabetics. Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232 [TBL] [Abstract][Full Text] [Related]
20. [Causes of insulin secretion disorders in non-insulin dependent diabetics. Comparison of in vivo results with examinations of isolated islet cells]. Lohmann D; Jahr H; Verlohren HJ; Zühlke H Z Gesamte Inn Med; 1981 Jan; 36(2):47-51. PubMed ID: 7013297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]